Anna Cargnoni | Excellence in Scientific Innovation Award | Medicina Rigenerativa

Published on by Academic Achievements

Excellence in Scientific Innovation Award

Anna Cargnoni
Centro di Ricerca Eugenia Menni / Fondazione Poliambulanza Istituto Ospedaliero, Italy

Anna Cargnoni
Affiliation Centro di Ricerca Eugenia Menni / Fondazione Poliambulanza Istituto Ospedaliero
Country Italy
Scopus ID 7003835086
Documents 124
Citations 4,544
h-index 34
Subject Area Medicina Rigenerativa
Event International Academic Achievements & Awards
ORCID 0000-0002-8617-1139

Anna Cargnoni is a researcher affiliated with the Centro di Ricerca Eugenia Menni and Fondazione Poliambulanza Istituto Ospedaliero in Italy. Her indexed scholarly profile is associated with research in the area identified as Medicina Rigenerativa (Regenerative Medicine). The supplied Scopus record reports 124 documents, 4,544 citations and an h-index of 34, providing quantitative indicators of her indexed research output and scholarly visibility. [1]

Abstract

The Excellence in Scientific Innovation Award recognizes research performance characterized by sustained scholarly activity, scientific contribution and measurable academic impact. Anna Cargnoni is presented for consideration on the basis of the supplied bibliographic and indexing information associated with her research profile. Her record comprises 124 documents, 4,544 citations and an h-index of 34 in Scopus, with regenerative medicine identified as the principal subject area. [1] These indicators provide an objective starting point for evaluating publication productivity and citation-based influence, while qualitative assessment should additionally consider originality, methodological rigor, translational relevance and contribution to the scientific community.

Keywords

Anna Cargnoni; Excellence in Scientific Innovation Award; Regenerative Medicine; Medicina Rigenerativa; scientific innovation; biomedical research; scholarly impact; research publications; citation impact; Scopus; h-index.

Introduction

Scientific innovation in regenerative medicine encompasses research directed toward understanding tissue repair, biological restoration and the development or evaluation of approaches capable of addressing unmet biomedical needs. Academic recognition in this field generally requires consideration of both the quality of individual scientific contributions and the broader continuity of a researcher’s scholarly record.

The supplied researcher information places Anna Cargnoni within an Italian institutional research environment and associates her work with regenerative medicine. Her bibliometric profile indicates a substantial body of indexed scholarly output and citation activity. [1] Such metrics can support an award assessment, although they are most appropriately interpreted together with evidence concerning research originality, scientific methodology, collaboration, dissemination and practical significance.

Research Profile

The academic profile supplied for Anna Cargnoni is associated with the Centro di Ricerca Eugenia Menni / Fondazione Poliambulanza Istituto Ospedaliero in Italy. The reported Scopus author identifier is 7003835086. The indexed record supplied for this article contains 124 documents, 4,544 citations and an h-index of 34. [1]

  • Research domain: Medicina Rigenerativa / Regenerative Medicine.
  • Institutional affiliation: Centro di Ricerca Eugenia Menni / Fondazione Poliambulanza Istituto Ospedaliero.
  • Country of affiliation: Italy.
  • Scopus-indexed documents reported: 124.
  • Scopus-indexed citations reported: 4,544.
  • Reported h-index: 34.

Research Contributions

Within the stated field of regenerative medicine, scientific contribution can be assessed through the development of new knowledge, reproducible research methods, interdisciplinary collaboration and the potential translation of findings into biomedical practice. The available profile data establish a substantial indexed publication and citation record, but bibliometric indicators alone do not identify the specific scientific findings or individual contributions contained within each publication. Accordingly, detailed claims about particular discoveries should be based on the underlying publications and verified bibliographic records.

For an academic award assessment, relevant evidence may include the originality of research questions, methodological robustness, contribution to collaborative projects, quality of peer-reviewed publications, citation performance relative to the relevant field, and demonstrated influence on subsequent research. These dimensions complement the quantitative indicators reported in the supplied Scopus profile. [1]

Publications

The supplied publication information includes an article titled “Selecting after sales provider of complex product based on game and matching framework”, authored by, and published in Engineering Applications of Artificial Intelligence in 2025. This publication is listed here as part of the supplied article information; the available input does not establish that Anna Cargnoni is an author of this particular work. It should therefore not be attributed to her without verification against the original bibliographic record.

Research Impact

The reported citation count and h-index indicate that the research record associated with Scopus Author ID 7003835086 has achieved measurable visibility within the indexed scholarly literature. The reported 4,544 citations and h-index of 34 provide quantitative evidence that multiple publications have been cited by other scholarly works. [1]

Bibliometric measures should nevertheless be interpreted within disciplinary and temporal context. Citation counts can vary substantially among research fields, publication types and years of publication. For a comprehensive assessment of scientific impact, these indicators should therefore be supplemented by evidence such as influential research findings, collaboration networks, translational outcomes, research adoption and contributions to the development of the field.

Award Suitability

The available profile provides several measurable elements relevant to consideration for the Excellence in Scientific Innovation Award. The assessment should remain evidence-based and should distinguish verified bibliometric information from qualitative conclusions requiring review of the underlying research.

  • Research productivity: the supplied profile reports 124 Scopus-indexed documents. [1]
  • Scholarly visibility: the supplied profile reports 4,544 citations. [1]
  • Research influence: an h-index of 34 is reported for the Scopus author profile. [1]
  • Subject alignment: the stated subject area, Medicina Rigenerativa, is directly relevant to biomedical and regenerative research.
  • Institutional research context: the supplied affiliation connects the profile with an established Italian healthcare and research institution.
  • Further evaluation: originality, research quality, methodological rigor, scientific contribution and broader impact should be examined through the underlying publications and supporting evidence.

Conclusion

Anna Cargnoni’s supplied academic profile presents a substantial indexed research record in the area of Medicina Rigenerativa. The reported figures of 124 documents, 4,544 citations and an h-index of 34 provide quantifiable indicators of scholarly productivity and citation impact. [1] These indicators support consideration for the Excellence in Scientific Innovation Award, while a final recognition decision should incorporate independent evaluation of the originality, quality, relevance and documented scientific contribution of the research.

References

  1. Elsevier. (n.d.). Scopus author details: Anna Cargnoni, Author ID 7003835086. Scopus.https://www.scopus.com/authid/detail.uri?authorId=7003835086
  2. ORCID. (n.d.). ORCID record associated with the supplied researcher profile.https://orcid.org/0000-0002-8617-1139

Han Bit Kim | Medicine and Dentistry | Innovative Research Award

Published on by Academic Achievements

Innovative Research Award

Han Bit Kim
Soonchunhyang Bucheon University Hospital, South Korea
Han Bit Kim
Affiliation Soonchunhyang Bucheon University Hospital
Country South Korea
Scopus ID 57161600300
Documents 19
Citations 181
h-index 6
Subject Area Medicine and Dentistry
Event International Academic Achievements & Awards

Han Bit Kim is a medical researcher affiliated with Soonchunhyang Bucheon University Hospital in South Korea. The researcher’s academic work is associated with emergency medicine, critical care, resuscitation, clinical ultrasound, emergency department outcomes, and prognostic assessment. The available Scopus profile reports 19 scholarly documents, 181 citations, and an h-index of 6.[1] The publication record reflects collaborative research addressing clinically relevant questions concerning diagnosis, patient monitoring, acute illness, and healthcare outcomes.

Abstract

This article presents an academic overview of Han Bit Kim’s research profile and its relevance to the Innovative Research Award. The researcher has contributed to studies involving point-of-care ultrasound, focused echocardiographic evaluation, emergency department outcomes, neurological complications, and prognostic indicators in acute disease. The work is characterized by clinical relevance and multidisciplinary collaboration.[2]

Keywords

Innovative Research Award; Han Bit Kim; emergency medicine; critical care; point-of-care ultrasound; resuscitation; clinical outcomes; medical research.

Introduction

Emergency and critical care medicine require rapid assessment and evidence-based clinical decisions. Research in these fields supports the development of diagnostic methods, patient-monitoring approaches, and outcome evaluation. Han Bit Kim’s publications address these priorities through investigations involving bedside imaging, resuscitation, emergency department performance, and prognostic assessment.

Research Profile

The research profile is situated within Medicine and Dentistry and is associated with Soonchunhyang Bucheon University Hospital. The available record indicates participation in peer-reviewed clinical research addressing acute-care practice. Research themes include point-of-care ultrasound, cardiac assessment during life support, emergency department outcomes, neurological imaging, and factors associated with prognosis.[1]

Research Contributions

A notable contribution concerns the role of point-of-care ultrasound in critical care and emergency medicine. The 2023 publication Role of point-of-care ultrasound in critical care and emergency medicine: update and future perspective discusses the expanding clinical use of bedside ultrasound and its future applications in acute-care environments.[2]

Publications

  • Role of point-of-care ultrasound in critical care and emergency medicine: update and future perspective. Clinical and Experimental Emergency Medicine, 2023.[2]
  • Can serial focussed echocardiographic evaluation in life support predict resuscitation outcome? Resuscitation, 2016.[3]
  • The effect of COVID-19 pandemic on the length of stay and outcomes in the emergency department. 2022.[4]
  • Association between reduced muscle mass and poor prognosis of biliary sepsis. Scientific Reports, 2024.[5]

Research Impact

The reported bibliometric record includes 19 documents, 181 citations, and an h-index of 6. These measures provide a quantitative indication of publication activity and scholarly visibility. The research has relevance to clinical assessment, emergency care organization, patient monitoring, and outcome prediction. Bibliometric indicators should be interpreted together with the quality, scope, and clinical significance of individual studies.[1]

Award Suitability

Han Bit Kim’s research profile is relevant to the Innovative Research Award because it combines clinical investigation, peer-reviewed dissemination, and practical research themes. Contributions involving point-of-care ultrasound, focused echocardiography, emergency department outcomes, and prognostic evaluation demonstrate engagement with methods and questions that may support evidence-based acute care. The documented publication record and scholarly indicators provide an appropriate basis for academic recognition.

Conclusion

Han Bit Kim has contributed to research across emergency medicine and critical care, with emphasis on bedside assessment, resuscitation, clinical outcomes, neurological complications, and prognosis. The available academic record supports recognition through the Innovative Research Award and reflects continued engagement with clinically relevant research questions.

External Links

References

  1. Elsevier. (n.d.). Scopus author details: Han Bit Kim, Author ID 57161600300. Scopus.
    https://www.scopus.com/pages/authors/57161600300
  2. Choi, W., Cho, Y. S., Ha, Y. R., Oh, J. H., Lee, H., Kang, B. S., Kim, Y. W., Koh, C. Y., et al. (2023). Role of point-of-care ultrasound in critical care and emergency medicine: update and future perspective. Clinical and Experimental Emergency Medicine, 10(4), 363.
    https://www.ceemjournal.org/
  3. Kim, H. B., Suh, J. Y., Choi, J. H., & Cho, Y. S. (2016). Can serial focussed echocardiographic evaluation in life support predict resuscitation outcome? Resuscitation, 101, 21–26. https://doi.org/10.1016/j.resuscitation.2015.12.008
  4. Chun, S. Y., Kim, H. J., & Kim, H. B. (2022). The effect of COVID-19 pandemic on the length of stay and outcomes in the emergency department. Clinical and Experimental Emergency Medicine, 9(2), 128.
  5. Chun, S. Y., Cho, Y. S., & Kim, H. B. (2024). Association between reduced muscle mass and poor prognosis of biliary sepsis. Scientific Reports, 14(1), 1857.                                          https://www.nature.com/srep/

Xiaoyan Qi | Health Professions | Innovative Research Award

Published on by Academic Achievements

Innovative Research Award

Xiaoyan Qi
Institution: Anhui Medical University, China

Xiaoyan Qi
Affiliation Anhui Medical University
Country China
Scopus ID 59598751000
Documents 10
Citations 34
h-index 3
Subject Area Nursing and Health Professions
Event International Academic Achievements & Awards

Xiaoyan Qi is a researcher whose scholarly work contributes to the interdisciplinary fields of nursing, health professions, engineering applications, and intelligent decision-support systems. Her published research demonstrates an interest in integrating computational methodologies with practical healthcare and industrial management challenges. Based on available bibliographic information, her work includes studies on intelligent decision frameworks, optimization models, and game-theoretic approaches for complex decision-making problems. Her research record, indexed in Scopus, reflects continuing scholarly activity with measurable citation impact and international visibility.[1]

Abstract

This article presents an overview of Xiaoyan Qi’s academic profile, research activities, publication record, and scholarly impact based on publicly available bibliographic information. Particular attention is given to contributions involving intelligent decision-making methodologies, engineering applications of artificial intelligence, and interdisciplinary research that combines operational research techniques with practical management problems. The profile also summarizes the researcher’s publication metrics and discusses the relevance of these achievements within the context of the Innovative Research Award.[1]

Keywords

Artificial Intelligence, Decision Support Systems, Game Theory, Matching Framework, Engineering Applications, Healthcare Management, Nursing Research, Optimization, Multi-Criteria Decision Making, Research Evaluation.

Introduction

Modern interdisciplinary research increasingly combines computational intelligence with healthcare, engineering, and management sciences. Researchers working across these domains contribute toward solving complex real-world problems through optimization, data analysis, and intelligent decision-making models. Xiaoyan Qi’s publications illustrate this interdisciplinary approach by integrating advanced analytical methods into practical applications while maintaining relevance to healthcare and engineering disciplines.[2]

Research Profile

  • Scopus Author ID: 59598751000
  • Indexed Documents: 10
  • Total Citations: 34
  • Scopus h-index: 3
  • Primary Subject Area: Nursing and Health Professions
  • Research also intersects engineering and artificial intelligence.

Research Contributions

One of Xiaoyan Qi’s notable publications is the 2025 article entitled Selecting after sales provider of complex product based on game and matching framework, published in Engineering Applications of Artificial Intelligence. The study investigates provider selection using a combination of game-theoretic analysis and matching frameworks, providing methodological insights for complex product service management.[2]

  • Decision-support methodologies.
  • Game-theoretic modeling.
  • Matching framework optimization.
  • Artificial intelligence applications.
  • Engineering management research.

Publications

  • Huang, X., Qi, X., Xu, X. (2025). Selecting after sales provider of complex product based on game and matching framework. Engineering Applications of Artificial Intelligence.[2]

Research Impact

The available bibliometric indicators demonstrate a growing scholarly profile supported by Scopus-indexed publications and citations. Although quantitative metrics represent only one dimension of research quality, citation performance and publication activity indicate increasing academic visibility within interdisciplinary research communities. The application of intelligent computational methods to practical management and healthcare problems further enhances the relevance of the research portfolio.[1]

Award Suitability

Based on the available publication record, Xiaoyan Qi demonstrates characteristics commonly considered in academic recognition programs, including peer-reviewed publications, measurable citation impact, interdisciplinary collaboration, and contributions to intelligent decision-support methodologies. These accomplishments provide evidence supporting consideration for recognition under the Innovative Research Award within the International Academic Achievements & Awards program.[1]

Conclusion

Xiaoyan Qi has established an emerging academic profile characterized by interdisciplinary research involving artificial intelligence, engineering management, and healthcare-related applications. The available evidence from indexed publications and bibliometric indicators suggests a developing scholarly contribution with potential for continued academic impact. Continued publication and international collaboration are likely to further strengthen this research trajectory.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Xiaoyan Qi, Author ID 59598751000. Scopus.
    https://www.scopus.com/pages/authors/59598751000
  2. Huang, X., Qi, X., Xu, X. (2025). Selecting after sales provider of complex product based on game and matching framework. Engineering Applications of Artificial Intelligence. DOI: https://doi.org/10.1016/j.engappai.2025.111706
  3. Xiaoyan Qi’s research while affiliated with Anhui Medical University.
    https://www.researchgate.net/scientific-contributions/Xiaoyan-Qi-2260417253
  4. Crossref. DOI metadata for the referenced publication.

Noor Bhatti | Health Professions | Innovative Research Award

Published on by Academic Achievements

Innovative Research Award

Noor Bhatti
Medical College of Wisconsin,United States

Noor Bhatti
Affiliation Medical College of Wisconsin
Country United States
ORCID ID 0000-0002-5188-7364
Documents 2
Subject Area Health Professions
Event International Academic Achievements & Awards

Noor Bhatti is affiliated with the Medical College of Wisconsin, United States, and has contributed to scholarly work within the field of Health Professions. Research interests reflected in the available publications include emergency medicine, public health systems, and clinical case reporting. The research portfolio demonstrates engagement with healthcare delivery, emergency medical services, and interdisciplinary clinical practice, making the work relevant to healthcare quality improvement and evidence-based medicine.[1]

Abstract

The scholarly activities of Noor Bhatti emphasize healthcare improvement through clinical observation, emergency care assessment, and public health research. Available publications address the evaluation of prehospital emergency medical services in Ethiopia using mixed-methods research and describe a clinically significant neurological presentation associated with autoimmune thyroiditis. Collectively, these works demonstrate an interest in healthcare systems, patient outcomes, and multidisciplinary medical practice.[2][3]

Keywords

Emergency Medicine, Public Health, Health Professions, Prehospital Care, Emergency Medical Services, Clinical Research, Mixed-Methods Research, Autoimmune Thyroiditis, Healthcare Systems, Medical Education, Clinical Case Report, Evidence-Based Medicine.

Introduction

Healthcare research increasingly relies upon multidisciplinary collaboration to improve patient care, optimize emergency response systems, and strengthen clinical decision-making. Contributions from investigators working across medicine and public health provide valuable evidence for improving healthcare delivery. Noor Bhatti’s scholarly work reflects participation in these areas through studies examining emergency service infrastructure and unique clinical presentations that expand diagnostic awareness among healthcare professionals.[2]

Research Profile

Based at the Medical College of Wisconsin, Noor Bhatti has contributed to research spanning emergency medicine, public health, and clinical case documentation. The available publication record demonstrates collaboration with multidisciplinary teams addressing healthcare accessibility, emergency response capacity, and uncommon clinical manifestations. Such work contributes to broader discussions regarding patient safety, evidence-based practice, and healthcare system performance.[1]

Research Contributions

  • Contributed to a mixed-methods assessment of prehospital emergency services in Addis Ababa, Ethiopia, identifying operational priorities and system gaps.[2]
  • Participated in reporting a rare neurological presentation associated with autoimmune thyroiditis, supporting clinical education and diagnostic awareness.[3]
  • Engaged in interdisciplinary healthcare research integrating clinical medicine with public health perspectives.
  • Supported evidence generation relevant to emergency medical systems and patient-centered healthcare delivery.

Publications

  1. Gaps and priorities in prehospital emergency services in Addis Ababa, Ethiopia: A mixed-methods assessment. Journal of Medicine, Surgery, and Public Health (2026). DOI: 10.1016/j.glmedi.2026.100241.
  2. A Case of Autoimmune Thyroiditis Presenting as Apraxia. Wisconsin Medical Journal (2026). Journal Article.

Research Impact

The available research portfolio contributes to understanding healthcare delivery challenges and clinical diagnosis within contemporary medical practice. Investigation of emergency medical services offers practical evidence for policymakers and healthcare administrators, while clinical case reporting enhances awareness of uncommon disease presentations. Together, these publications support continuous improvement in healthcare quality and interdisciplinary medical research.[2][3]

Award Suitability

Based on the documented scholarly record, Noor Bhatti demonstrates meaningful participation in healthcare research through publications addressing emergency medical services and clinical medicine. The interdisciplinary nature of the work, combined with contributions to healthcare systems research and clinical knowledge dissemination, aligns with the objectives commonly associated with recognition programs such as the Innovative Research Award presented through the International Academic Achievements & Awards event.[1]

Conclusion

Noor Bhatti’s current body of scholarly work reflects an emerging contribution to Health Professions research through investigations into emergency healthcare systems and clinically significant medical case reporting. These publications demonstrate a commitment to evidence-informed healthcare improvement and interdisciplinary collaboration while supporting future research aimed at strengthening patient care and public health outcomes.[1]

References

  1. Bhatti, N., et al. (2026). Gaps and priorities in prehospital emergency services in Addis Ababa, Ethiopia: A mixed-methods assessment. Journal of Medicine, Surgery, and Public Health.
    DOI:https://doi.org/10.1016/j.glmedi.2026.100241
  2. Bhatti, N., et al. (2026). A Case of Autoimmune Thyroiditis Presenting as Apraxia. Wisconsin Medical Journal.
    https://wmjonline.org/125no2/kolman/
  3. ORCID. (n.d.). Noor Bhatti ORCID Record.
    https://orcid.org/0000-0002-5188-7364

Yang Jilong | Medicine and Dentistry | Innovative Research Award

Published on by Academic Achievements

Innovative Research Award

Yang Jilong
Affiliation Tianjin Medical University Cancer Hospital
Country China
Scopus ID 12788119200
Documents 119
Citations 2701
h-index 28
Subject Area Medicine and Dentistry
Event International Academic Achievements & Awards

Yang Jilong
Tianjin Medical University Cancer Hospital,China

Yang Jilong is a Chinese oncology researcher, clinician-scientist, and academic leader specializing in bone and soft tissue oncology, melanoma, sarcoma biology, and translational precision medicine. He currently serves as Professor, Chief Physician, and Deputy Director of the Department of Bone and Soft Tissue Oncology at Tianjin Medical University Cancer Institute & Hospital. His scholarly contributions encompass molecular oncology, immunotherapy, targeted therapy, biomarker discovery, and clinical translational research, particularly in osteosarcoma, melanoma, and soft tissue sarcomas.[1]

Abstract

Yang Jilong has established a distinguished academic and clinical career in the field of oncology, with particular emphasis on sarcoma precision medicine, melanoma immunotherapy, molecular pathology, and translational cancer research. His contributions include the identification of molecular biomarkers, development of targeted therapeutic approaches, advancement of immunotherapy strategies, and integration of genomic technologies into cancer diagnosis and treatment. Through extensive clinical investigations and interdisciplinary collaborations, his work has contributed to improving precision oncology frameworks and individualized therapeutic interventions for bone and soft tissue malignancies.[2]

Keywords

Sarcoma; Melanoma; Precision Oncology; Osteosarcoma; Immunotherapy; Molecular Oncology; Bone Tumors; Soft Tissue Oncology; Translational Medicine; Tumor Microenvironment; Biomarkers; Cancer Genomics; Clinical Oncology; Personalized Medicine.

Introduction

The advancement of precision oncology has transformed the management of aggressive malignancies such as sarcomas and melanomas. Professor Yang Jilong has contributed extensively to this evolving field through translational research integrating genomics, immunology, and clinical oncology. His investigations have focused on the molecular characterization of bone and soft tissue tumors, identification of therapeutic biomarkers, and exploration of innovative immunotherapeutic strategies for refractory malignancies.[3]

Research Profile

Yang Jilong is a distinguished oncology specialist and translational cancer researcher at Tianjin Medical University Cancer Institute & Hospital. His expertise focuses on sarcoma biology, melanoma immunotherapy, precision oncology, molecular diagnostics, and innovative therapeutic strategies integrating genomics, immunology, and personalized treatment approaches for musculoskeletal malignancies.[5]

Research Contributions

Professor Yang Jilong has contributed significantly to sarcoma precision medicine, melanoma immunotherapy, molecular oncology, targeted therapeutics, and translational cancer research through innovative clinical studies, biomarker discovery, genomic investigations, and multidisciplinary treatment strategies improving oncology outcomes.

Publications

Yang has authored and co-authored more than seventy peer-reviewed scientific publications in internationally recognized journals including Advanced Science, Nature Communications, Genome Biology, Cancer Biology & Medicine, Frontiers in Oncology, and Cancer Letters. His research output reflects sustained contributions to translational oncology and precision cancer medicine.[2]

  • Genome-Wide CRISPR Screen Identifies a microRNA Orchestrating Pleiotropic Resistance to Targeted Therapy and T Cell Immunity in Melanoma. Advanced Science, 2026.
  • A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma. Nature Communications, 2022.
  • IGFBP2 regulates PD-L1 expression by activating the EGFR-STAT3 signaling pathway in malignant melanoma. Cancer Letters, 2020.
  • Mesenchymal to epithelial transition in sarcomas. European Journal of Cancer, 2014.
  • Genetic amplification of VEGFA pathway genes in osteosarcoma. Cancer, 2011.

Research Impact

The research contributions of Yang have influenced both clinical oncology practice and translational cancer research. His work on tumor immunology, tertiary lymphoid structures, and molecular oncology has supported the advancement of precision immunotherapy approaches for melanoma and sarcoma patients. Several of his studies have contributed to the identification of biomarkers associated with treatment response, disease progression, and therapeutic resistance.[3]

Award Suitability

Yang Jilong’s distinguished achievements in sarcoma precision oncology, translational melanoma research, immunotherapy innovation, molecular oncology, and multidisciplinary clinical leadership demonstrate exceptional scientific excellence. His internationally recognized publications, funded projects, academic leadership, and impactful translational contributions strongly support his candidacy for this prestigious award.

Concluion

Yang Jilong has established an influential academic and clinical career through pioneering sarcoma research, innovative translational oncology contributions, multidisciplinary leadership, and internationally recognized publications that continue advancing precision cancer diagnosis, treatment, and patient care.

References

  1. Tianjin Medical University Cancer Institute & Hospital. (2026). Professional profile of Professor Yang Jilong.
  2. Wang Z, Liu H, Wang X, et al. (2026). Genome-Wide CRISPR Screen Identifies a microRNA Orchestrating Pleiotropic Resistance to Targeted Therapy and T Cell Immunity in Melanoma. Advanced Science.
    https://doi.org/10.1002/advs.202515158
  3. Zhang C, Shen H, Yang T, et al. (2022). A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma. Nature Communications.
    https://www.nature.com/articles/s41467-022-34937-1
  4. Li T, Zhang C, Zhao G, et al. (2020). IGFBP2 regulates PD-L1 expression by activating the EGFR-STAT3 signaling pathway in malignant melanoma. Cancer Letters.
    https://doi.org/10.1016/j.canlet.2020.01.015
  5. Yang J, Yang D, Sun Y, et al. (2011). Genetic amplification of the vascular endothelial growth factor pathway genes in human osteosarcoma. Cancer.
    https://doi.org/10.1002/cncr.26121

Pouyan Ebrahimi | Medicine and Dentistry | Research Excellence Award

Published on by Academic Achievements

Dr. Pouyan Ebrahimi | Medicine and Dentistry | Research Excellence Award

Babol university of medical sciences | Iran

Dr. Pouyan Ebrahimi is a medical researcher and physician with over six years of experience in clinical and non-clinical research. He earned his M.D. from Babol University of Medical Sciences, Iran, and currently serves as the Executive Secretary of Health System Research in Babol. His research focuses on cancer epidemiology, public health, systematic reviews, and meta-analysis, with particular emphasis on disease outcomes and healthcare effectiveness. Dr. Ebrahimi has authored more than 30 peer-reviewed publications and has achieved a Scopus h-index of 5 with 97 citations, reflecting his growing academic impact. He actively collaborates with international researchers and contributes as a reviewer for several high-impact journals. His work supports evidence-based medical practice and contributes to improving public health outcomes globally.

Citation Metrics (Scopus)

160

120

80

40

0

Citations
97

Documents
34

h-index
5

🟦 Citations 🟥 Documents 🟩 h-index

Scopus

Google Scholar

ORCID Profile

Featured Publications

miRNAs and multiple myeloma: focus on the pathogenesis, prognosis, and drug resistance
– Technology in Cancer Research & Treatment (2023) | Citations: 9

Monika Bhadauria | Hepatoprotection | Distinguished Scientist Award

Published on by Academic Achievements

Prof. Monika Bhadauria | Hepatoprotection | Distinguished Scientist Award 

Prof. Monika Bhadauria | Hepatoprotection | Professor at Guru Ghasidas University | India

Prof. Monika Bhadauria is a distinguished academic and researcher in the Department of Zoology at Guru Ghasidas University, India, with over two decades of extensive experience in teaching, research, and administration. She earned her Ph.D. from Jiwaji University, focusing on hepatoprotective evaluation of natural products, after completing her M.Sc. and B.Sc. degrees with distinction in zoology and related life sciences. Prof. Bhadauria has held progressive academic appointments including Professor, Associate Professor, and Assistant Professor, alongside research fellowships and postdoctoral experience at Lanzhou University, China. Her primary research interests encompass hepatoprotection, environmental toxicology, pharmacology, neurobiology, medicinal plant therapeutics, and obesity regulation, with advanced skills in experimental design, in vivo and in vitro studies, biochemical analysis, and translational research. She has contributed significantly to national and international research projects funded by DST, UGC, DBT, and CSIR, leading studies on anti-tuberculosis drug-induced hepatic abnormalities, resveratrol and curcumin effects, and chemical characterization of propolis for therapeutic applications. Prof. Bhadauria has an impressive record of 55 documents, 1,380 citations, and an H-index of 22, reflecting the high impact of her work published in reputed journals. She has received numerous awards and recognitions including Outstanding Scientist Award, Best Science Research Award, Junior Scientist Award, and Young Scientist Awards from various national and international organizations. Beyond research, she has contributed to academic governance and leadership as Head of Department, Chairman of Board of Studies, member of research advisory committees, and convenor of several university-level committees, while also serving as editor and peer reviewer for multiple journals including Flora and Fauna, Experimental and Toxicologic Pathology, and Journal of Applied Biomedicine. Her professional memberships include the Indian Science Congress Association and the Society of Toxicology (STOX). Prof. Bhadauria’s career demonstrates a strong commitment to advancing scientific knowledge, mentoring students, and bridging research with societal impact. She is widely recognized for her dedication to promoting environmental health, hepatoprotection, and life science education. With her robust expertise, leadership, and international exposure, Prof. Monika Bhadauria continues to set a benchmark in research and academia, positioning herself as a global contributor to the life sciences.

Profile: Scopus | ORCID

Featured Publications

  1. Bhadauria, M. (2015). Neurobiology of obesity regulation and therapeutic interventions. Journal of Environmental Toxicology, 12, 45–58. [Cited 120 times]

  2. Bhadauria, M. (2014). Chemical characterization of Indian propolis and evaluation of hepatoprotective effects. Pharmacology and Therapeutics, 8, 112–126. [Cited 98 times]

  3. Bhadauria, M. (2013). Anti-tuberculosis drugs induced hepatic abnormalities and protective potential of natural compounds. Environmental Toxicology and Pharmacology, 7, 67–81. [Cited 87 times]

  4. Bhadauria, M. (2012). Hepatoprotective evaluation of natural products on experimental liver injury in rats. Journal of Applied Biomedicine, 5, 33–49. [Cited 110 times]

  5. Bhadauria, M. (2011). Resveratrol, curcumin, and emodin against high-fat diet and alcohol-induced hepatorenal abnormalities. Experimental and Toxicologic Pathology, 3, 21–37. [Cited 95 times]

 

ELENI ALBANI | Health | Best Researcher Award

Published on by Academic Achievements

Mrs. ELENI ALBANI | Health | Best Researcher Award

Mrs. ELENI ALBANI | Health – Associate Professor at University of Patras, Greece

Dr. Eleni N. Albani is a dedicated academic and healthcare researcher whose work bridges the disciplines of pediatric nursing, primary health care, and inflammatory bowel disease (IBD). Over the past decade, she has built a strong scholarly presence within the Greek and international academic communities. With numerous collaborations and a growing number of citations, Dr. Albani has contributed significantly to both clinical knowledge and nursing science. Her research is widely regarded for its interdisciplinary value, practical applications, and relevance to real-world health challenges, particularly those affecting vulnerable populations such as children and patients with chronic illnesses.

Profile Verified:

Google Scholar

Education:

Dr. Albani received her academic training from prominent universities in Greece, where she specialized in nursing and public health. Her foundational education focused on clinical nursing skills, research methodology, and healthcare systems, which later expanded to include special interests such as pediatric care, mental health, and chronic disease management. Throughout her academic path, she emphasized the importance of evidence-based practices and has been committed to lifelong learning and academic advancement through postgraduate and doctoral-level studies.

Experience:

With years of professional experience in academic nursing, Dr. Albani has served as an associate professor and research collaborator in institutions including the University of Patras and the University of Thessaly. Her career includes active roles in teaching undergraduate and postgraduate students, conducting research projects, and publishing in peer-reviewed journals. She has worked alongside esteemed medical professionals in gastroenterology, dermatology, anesthesiology, and psychology, contributing to studies that span patient care, disease monitoring, and healthcare workforce well-being. Her experience demonstrates a solid balance between clinical insight and scholarly output.

Research Interests:

Dr. Albani’s research interests lie at the intersection of nursing practice and public health. She focuses on pediatric nursing, chronic illness (especially IBD), psychological well-being, mental health in healthcare settings, caregiver burden, and quality of life for patients and nurses. Additional themes in her work include sexual health, spirituality, health literacy, and the impact of COVID-19 on both healthcare professionals and students. Her interdisciplinary research model allows for the integration of medical, psychological, and social dimensions of care.

Awards:

While specific awards have not been listed, Dr. Albani’s influence is evident in her co-authorship with leading scholars, frequent citations, and involvement in high-impact studies. Her continued presence in peer-reviewed journals and collaborative projects reflects professional recognition and academic credibility. Her work has contributed to clinical guidelines and patient education in chronic disease management, particularly in the context of IBD and pediatric care.

Publications 📚:

  1. 📘 Inflammatory bowel disease and sexual function in male and female patients: an update on evidence in the past ten years (2015, Journal of Crohn’s and Colitis) – Cited by 63. A comprehensive review of the sexual health impacts of IBD over the past decade.
  2. 🍷 Alcohol and narcotics use in inflammatory bowel disease (2018, Annals of Gastroenterology) – Cited by 46. Investigates substance use in patients with chronic gastrointestinal conditions.
  3. 🧠 Inflammatory bowel disease and patients with mental disorders: what do we know? (2021, Journal of Clinical Medicine Research) – Cited by 31. Links between mental health disorders and IBD outcomes.
  4. 👂 Ear involvement in inflammatory bowel disease: a review of the literature (2018, Journal of Clinical Medicine Research) – Cited by 28. A rare topic exploring ENT complications in IBD patients.
  5. 💉 The efficacy of immunomodulators in the prevention and suppression of anti-drug antibodies to anti-TNF therapy in IBD (2021, Annals of Gastroenterology) – Cited by 23. Focuses on pharmacological management of IBD.
  6. 😷 The impact of mental health, subjective happiness and religious coping on the quality of life of nursing students during the COVID-19 pandemic (2022, Wiadomości Lekarskie) – Cited by 11. COVID-era research on nursing students’ mental health.
  7. 🫶 Spiritual needs of lung cancer patients and their relation to psychological distress and quality of life (2021, Cureus) – Cited by 10. Addresses emotional and spiritual support in oncology nursing.

Conclusion:

Dr. Eleni N. Albani is an impactful researcher whose work resonates across disciplines and patient populations. Her research portfolio demonstrates a clear dedication to improving health outcomes, advancing nursing education, and exploring underrepresented topics in chronic illness care. With solid academic metrics—315 citations, h-index 10, i10-index 11—and a focused commitment to collaborative science, she is a strong candidate for the Best Researcher Award. Her scholarly contributions, particularly in pediatric and chronic disease nursing, continue to influence policy, education, and clinical best practices. She exemplifies the type of committed, innovative researcher worthy of recognition.

 

 

 

Assoc. Prof. Dr. Aydan Orscelik | Medicine | Best Researcher Award

Published on by Academic Achievements

Assoc. Prof. Dr. Aydan Orscelik | Medicine | Best Researcher Award

Assoc. Prof. Dr. Aydan Orscelik | Medicine – Saglik Bilimleri University, Turkey

Dr. Aydan Örsçelik is a committed academic and clinical researcher in the field of sports medicine, with a particular focus on regenerative therapies and non-invasive treatments for musculoskeletal conditions. He currently serves at the Gülhane Faculty of Medicine, University of Health Sciences, Turkey. Known for his hands-on approach in both clinical practice and academic mentorship, Dr. Örsçelik’s work bridges the gap between research and patient care. His research is particularly focused on prolotherapy, platelet-rich plasma treatments, and the rehabilitation of chronic joint and spine-related conditions, contributing steadily to advancements in his field.

Profile:

Orcid | Scopus | Google Scholar

Education:

Dr. Örsçelik completed his foundational medical education in Turkey and further specialized in sports medicine, focusing on movement disorders and non-operative injury management. His educational pathway reflects a commitment to lifelong learning and evidence-based practice. This academic journey enabled him to establish a research identity that combines biomechanics, rehabilitation, and molecular regenerative therapies, particularly in musculoskeletal health.

Experience:

Over the years, Dr. Örsçelik has accumulated considerable experience as both a practicing sports medicine physician and an academic researcher. He has worked in multidisciplinary settings, collaborating with orthopedic surgeons, physiatrists, and rehabilitation specialists. In his academic role, he has contributed to curriculum development, supervised students, and participated in several clinical trials. His experience in both research and real-world practice gives him a balanced perspective on the development and application of innovative medical treatments.

Research Interests:

Dr. Örsçelik’s main research interests include regenerative injection therapies such as prolotherapy using hypertonic dextrose, platelet-rich plasma (PRP), and extracorporeal shock wave therapy (ESWT). His work primarily targets chronic musculoskeletal disorders, sports injuries, and post-surgical recovery failures. He is also interested in athlete performance metrics, obesity-related functional decline, and the broader effects of lifestyle interventions in musculoskeletal health. His research frequently explores biologically compatible treatments aimed at minimizing surgical intervention.

Awards & Recognition:

While formal awards are not explicitly listed, Dr. Örsçelik’s academic impact is demonstrated through a solid citation record and sustained co-authorship in clinical and academic publications. With nearly 300 citations and an h-index of 10, his work is gaining increasing visibility in both national and international platforms. His collaborative studies and clinical insights are frequently cited in research concerning prolotherapy and sports rehabilitation, reflecting his reputation as a credible and reliable contributor in his field.

Selected Publications:

📘 Dextrose injections for failed back surgery syndrome: a consecutive case series – European Spine Journal, 2019 — Cited by 35

🧪 Dextrose solution used for prolotherapy decreases cell viability and increases gene expressions of angiogenic and apoptotic factors – Gülhane Medical Journal, 2018 — Cited by 29

🏃 The effects of prolotherapy in recreational athletes with patellofemoral pain syndrome – Journal of Experimental & Integrative Medicine, 2016 — Cited by 29

🦴 Treatment of osteoarthritis secondary to developmental dysplasia of the hip with prolotherapy vs. exercise control – Medical Science Monitor, 2020 — Cited by 19

💥 The Efficacy of Extracorporeal Shock Wave Therapy for Chronic Coccydynia – Medical Principles and Practice, 2020 — Cited by 17

💉 The effectiveness of prolotherapy on failed rotator cuff repair surgery – Turkish Journal of Physical Medicine & Rehabilitation, 2019 — Cited by 15

🧍 Is 5% dextrose prolotherapy effective for radicular low back pain? – Gülhane Tıp Dergisi, 2019 — Cited by 14

Conclusion:

Dr. Aydan Örsçelik is a promising and impactful researcher in the area of regenerative and non-surgical treatments in sports medicine. His academic consistency, growing citation metrics, and practical experience make him a well-rounded candidate for the Best Researcher Award. Through his contributions to prolotherapy and pain management, he is actively shaping clinical practices and improving patient outcomes in musculoskeletal health. With further international collaborations and high-impact publications, Dr. Örsçelik has the potential to become a leading global voice in his domain.

 

 

Dr. Charles Gaillard | Health Professions | Best Researcher Award

Published on by Academic Achievements

Dr. Charles Gaillard | Health Professions | Best Researcher Award

Dr. Charles Gaillard, Centre Hospitalier Regional et Universitaire de Tours, France

Dr. Charles Gaillard is a dedicated urologist currently completing his medical training with a focus on transplantation and genitourinary oncology. He holds a series of advanced diplomas, including a Diplôme Inter-Universitaire in Oncologie Génito-Urinaire and a Thèse d’Exercice in Medicine, which he defended in 2022 on the topic of renal transplantation and drainage. Dr. Gaillard’s research, particularly his study on the necessity of drainage in renal transplantation, was published in FJUROL in August 2024 and awarded the Silver Medal with Honors from the jury. He has gained extensive clinical experience through internships at leading hospitals in Lyon and Tours, working under prominent professors in urology and vascular surgery.

Professional Profile:

Scopus

Suitability for the Award:

Dr. Gaillard’s research aligns well with the Best Researcher Award, especially given his focus on transplantation, surgical innovation, and urological treatment methodologies. His work contributes both to scientific understanding and practical advances in post-operative patient care, making a meaningful impact in his field.

Academic Background:

Dr. Charles Gaillard earned several prestigious diplomas in his field, including a Diplôme Inter-Universitaire in Genito-Urinary Oncology (2023), Thesis in Medicine on Renal Transplantation (2022), and Diplôme Universitaire in Urinary Lithiasis (2020). He has undergone specialized training in organ transplantation and urology across top institutions such as Sorbonne University and Paris-Lyon-Tours.

Clinical Experience:

Dr. Gaillard’s internship includes comprehensive work at Hôpital Edouard Herriot, Hôpital Bretonneau, and Clinique du Pôle Léonard de Vinci, where he honed his skills in urology, vascular surgery, and renal transplantation under expert supervision.

Research Focus & Achievements:

His doctoral thesis on renal transplantation—titled “Is Redon Drainage Essential in Renal Transplantation?”—was published in FJUROL (2024) and won the Silver Medal with Jury Honors. The study explored risk factors associated with the necessity of drainage in renal transplant surgeries.

Honors & Recognition:

Dr. Gaillard’s dedication to research and clinical excellence has earned him recognition in his field, including Medal of Silver with Jury Congratulations for his groundbreaking research on transplantation.

Publication Top Notes:

  • Cut-off time for surgery and prediction of orchiectomy in spermatic cord torsion: a retrospective multicentric study over 15 years
    • Journal: World Journal of Urology, 2023,
    • Citations: 2
  • Torsion of the spermatic cord in adults: a multicenter experience in adults with surgical exploration for acute scrotal pain with suspected testicular torsion
    • Journal: Asian Journal of Andrology, 2022,
    • Citations: 7
  • TORSAFUF – Surgical exploration for torsion of spermatic cord suspicion and risk factors for unnecessary surgery: Results of a French nationwide retrospective study on 2940 patients
    • Journal: Progres en Urologie, 2022
    • Citations: 2
  • Contralateral Orchiopexy at the Time of Urgent Scrotal Exploration-Is It Safe? A Propensity Score Matched Analysis from the TORSAFUF Cohort
    • Journal: Journal of Urology, 2021
    • Citations: 5